Literature DB >> 15158619

Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.

Elena Soto-Vega1, Ricardo García-Muñoz, Yvonne Richaud-Patin, Joaquín Zúñiga-Ramos, José Carlos Crispín, Efraín Díaz-Jouanen, Luis Felipe Flores-Suárez, Luis Llorente, Julio Granados.   

Abstract

Behçet's disease is a multi-system inflammatory disorder of unknown etiology. The disease is more prevalent in Eastern Mediterranean countries and Japan where there is a linkage to HLA-B51. Mexican Mestizos are suitable subjects for studying the role of ethnicity in the susceptibility to Behçet's disease. High-resolution HLA class I and class II typing was performed by polymerase chain reaction sequence-specific oligonucleotide (PCR-SSO) reverse dot blot and PCR-single-strand polymorphism in 32 patients with Behçet's disease and 99 healthy ethnically-matched controls. A significant increased frequency of HLA-B(*)44 (P = 0.02; OR = 2.78; CI 95% = 1.1-7.7), HLA-B(*)52 (P = 0.02; OR = 5.33; CI 95% = 1.07-29.1), and HLA-B(*)56 (P = 0.003; OR = 4.19; CI 95% = 3.37-5.21) as well as HLA-DRB1(*)01 and HLA-DRB1(*)13 (p = 0.007; OR = 3.36; CI 95% = 1.22-9.27) was found in Mexican patients with Behçet's disease when compared to controls. The low frequency of native markers in Mexican Mestizo patients with Behçet's disease suggests that genetic admixture between Eastern Mediterraneans and Orientals with Amerindians is a recent event that increased the risk of developing Behçet's disease in the Mexican population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158619     DOI: 10.1016/j.imlet.2004.03.017

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  An update on the genetics of HLA B27-associated acute anterior uveitis.

Authors:  Tammy M Martin; James T Rosenbaum
Journal:  Ocul Immunol Inflamm       Date:  2011-04       Impact factor: 3.070

3.  HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.

Authors:  Ayfer Atalay; Sanem Yildiz-Demirtepe; Sinan Tatlipinar; Berna Sanli-Erdoğan; Veli Cobankara; Cem Yildirim; Hüseyin Bağci; Erol Omer Atalay
Journal:  Mol Biol Rep       Date:  2007-06-27       Impact factor: 2.316

Review 4.  Vasculitis: report from Mexico.

Authors:  Luis Felipe Flores-Suárez
Journal:  Clin Exp Nephrol       Date:  2012-12-11       Impact factor: 2.801

5.  Characterization of the major histocompatibility complex locus association with Behçet's disease in Iran.

Authors:  Joana M Xavier; Fereydoun Davatchi; Olga Abade; Farhad Shahram; Vânia Francisco; Bahar Sadeghi Abdollahi; Hélder Trindade; Abdolhadi Nadji; Niloofar Mojarad Shafiee; Fahmida Ghaderibarmi; Dário Ligeiro; Sofia A Oliveira
Journal:  Arthritis Res Ther       Date:  2015-03-19       Impact factor: 5.156

6.  HLA and non-HLA genes in Behçet's disease: a multicentric study in the Spanish population.

Authors:  Marco Antonio Montes-Cano; Marta Conde-Jaldón; José Raul García-Lozano; Lourdes Ortiz-Fernández; Norberto Ortego-Centeno; María Jesús Castillo-Palma; Gerard Espinosa; Genaro Graña-Gil; Miguel Angel González-Gay; Ana Celia Barnosi-Marín; Roser Solans; Patricia Fanlo; Teresa Camps; Santos Castañeda; Juan Sánchez-Bursón; Antonio Núñez-Roldán; Javier Martín; María Francisca González-Escribano
Journal:  Arthritis Res Ther       Date:  2013-10-04       Impact factor: 5.156

7.  HLA-A, B (Class I) and HLA-DR, DQ (Class II) antigens in Turkish patients with recurrent aphthous ulceration and Behçet's disease.

Authors:  Filiz Namdar Pekiner; Emre Aytugar; Gülderen Yanikkaya Demirel; M Oğuz Borahan
Journal:  Med Princ Pract       Date:  2013-03-07       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.